20-45630963-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_080753.3(WFDC10A):c.185C>A(p.Ala62Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000093 in 1,612,128 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_080753.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WFDC10A | NM_080753.3 | c.185C>A | p.Ala62Glu | missense_variant | 2/2 | ENST00000372643.4 | NP_542791.1 | |
WFDC9 | NM_147198.4 | c.-153+240G>T | intron_variant | ENST00000326000.2 | NP_671731.1 | |||
WFDC10A | XM_017027679.2 | c.167C>A | p.Ala56Glu | missense_variant | 2/2 | XP_016883168.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WFDC10A | ENST00000372643.4 | c.185C>A | p.Ala62Glu | missense_variant | 2/2 | 1 | NM_080753.3 | ENSP00000361726.3 | ||
WFDC9 | ENST00000326000.2 | c.-153+240G>T | intron_variant | 1 | NM_147198.4 | ENSP00000320532.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151994Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000724 AC: 18AN: 248730Hom.: 0 AF XY: 0.0000595 AC XY: 8AN XY: 134434
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1460016Hom.: 0 Cov.: 34 AF XY: 0.00000551 AC XY: 4AN XY: 726328
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152112Hom.: 0 Cov.: 31 AF XY: 0.0000403 AC XY: 3AN XY: 74354
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 20, 2024 | The c.185C>A (p.A62E) alteration is located in exon 2 (coding exon 2) of the WFDC10A gene. This alteration results from a C to A substitution at nucleotide position 185, causing the alanine (A) at amino acid position 62 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at